Pulmonary arterial hypertension trials in Lithuania

4 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

  Where

  Kaunas

  Age

  18 years to 75 years

  People

  330 worldwide

  Run by

  Gossamer Bio USA, Inc.

  See details and how to joinNCT06274801 · EU 2023-506334-75-00
• Phase 3Taking people
  A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

  Where

  Kaunas

  Age

  18 years to 75 years

  People

  344 worldwide

  Run by

  Insmed Incorporated

  See details and how to joinNCT07481981 · EU 2026-525265-48-00
• Phase 3Taking people
  An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

  Where

  Kaunas

  Age

  18 years to 75 years

  People

  486 worldwide

  Run by

  Inhibikase Therapeutics

  See details and how to joinNCT07365332 · EU 2024-520218-23-00
• No phaseNot yet taking people in Lithuania
  Training in HFpEF-PH

  Where

  Vilnius

  Age

  18 years and over

  People

  90 worldwide

  Run by

  Heidelberg University

  See details and how to joinNCT05464238